Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
doerings, University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT00714311
First received: July 9, 2008
Last updated: February 4, 2015
Last verified: February 2015
Results First Received: February 4, 2015  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Outcomes Assessor);   Primary Purpose: Treatment
Condition: Borderline Personality Disorder
Interventions: Behavioral: Transference-Focused Psychotherapy
Behavioral: treatment by experienced community psychotherapists

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Transferenced-Focused Psychotherapy Transferenced-Focused Psychotherapy (TFP)
Experienced Community Psychotherapists Experienced Community Psychotherapists (ECP)

Participant Flow:   Overall Study
    Transferenced-Focused Psychotherapy     Experienced Community Psychotherapists  
STARTED     52     52  
COMPLETED     39     30  
NOT COMPLETED     13     22  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Transferenced-Focused Psychotherapy Transferenced-Focused Psychotherapy (TFP)
Experienced Community Psychotherapists Experienced Community Psychotherapists (ECP)
Total Total of all reporting groups

Baseline Measures
    Transferenced-Focused Psychotherapy     Experienced Community Psychotherapists     Total  
Number of Participants  
[units: participants]
  52     52     104  
Age  
[units: participants]
     
<=18 years     0     0     0  
Between 18 and 65 years     52     52     104  
>=65 years     0     0     0  
Age  
[units: years]
Mean (Standard Deviation)
  27.46  (6.8)     27.19  (7.5)     27.33  (7.11)  
Gender  
[units: participants]
     
Female     52     52     104  
Male     0     0     0  
Region of Enrollment  
[units: participants]
     
Austria     20     20     40  
Germany     32     32     64  



  Outcome Measures

1.  Primary:   Drop-out   [ Time Frame: 1 year ]

2.  Primary:   Suicidality (Suicide Attempts)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

3.  Secondary:   Psychosocial Functioning (Global Assessment of Functioning, GAF-Score)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

4.  Secondary:   Level of Personality Organization (Structured Interview for Personality Organization, STIPO)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

5.  Secondary:   Number of Self-harming Acts   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

6.  Secondary:   Self-assessment of Psychopathology (BDI, STAI, BSI)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

7.  Secondary:   Attachment Style and Reflective Function (Adult Attachment Interview, AAI)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No

8.  Secondary:   Borderline Symptomatology (DSM-IV Criteria)   [ Time Frame: 1 month ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.   Safety Issue:   No


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Stephan Doering
Organization: Medical University of Vienna
phone: +43140400 ext 25190
e-mail: stephan.doering@meduniwien.ac.at


Publications:
Publications automatically indexed to this study:

Responsible Party: doerings, University Hospital Muenster
ClinicalTrials.gov Identifier: NCT00714311     History of Changes
Other Study ID Numbers: 1106/04, 10636, DPG0802
Study First Received: July 9, 2008
Results First Received: February 4, 2015
Last Updated: February 4, 2015
Health Authority: Germany: Ethics Commission